-
Recognizing that patients and consumers are the key players in healthcare, all employees are recommended to spend 1% of their working hours with patients
-
We strive to improve access to medicines through the development and provision of innovative medicines.
-
October 15, 2019
NEW DRUG APPROVAL FOR FYCOMPA® FOR ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN CHINA
-
October 1, 2019
-
September 30, 2019
EISAI AND NICHI-IKO ENTER INTO COLLABORATION AGREEMENT FOR GENERIC PHARMACEUTICAL BUSINESS IN CHINA
-
September 26, 2019
-
September 26, 2019
EISAI AND FRONTEO TO LAUNCH COROBAN®
TUMBLING AND FALLING PREDICTION SYSTEM FOR INPATIENTS
-
October 9, 2019
-
October 7, 2019
-
October 7, 2019
-
September 2, 2019
-
August 1, 2019
-
October 18, 2019
EISAI JOINS WORLD ECONOMIC FORUM AS STRATEGIC PARTNER ASSOCIATE
-
July 8, 2019
-
July 4, 2019
-
December 6, 2018
EISAI JOINS WORLD ECONOMIC FORUM CENTRE FOR THE FOURTH INDUSTRIAL REVOLUTION JAPAN
-
August 1, 2017
Eisai's hhc Philosophy
Sustainability
28 countries 1.9 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of September 2019)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
